Development of Safe and Non-Self-Immunogenic Mucosal Adjuvant by Recombinant Fusion of Cholera Toxin A1 Subunit with Protein Transduction Domain

Defending the mucosa: adjuvant and carrier formulations for mucosal immunity

(2011) Louise B Lawson et al.   CURRENT OPINION IN IMMUNOLOGY

Sublingual Immunization with M2-Based Vaccine Induces Broad Protective Immunity against Influenza

(2011) Byoung-Shik Shim et al.   PLoS One

Vaccine Adjuvants: Putting Innate Immunity to Work

(2010) Robert L. Coffman et al.   IMMUNITY

Mucosal adjuvants and long-term memory development with special focus on CTA1-DD and other ADP-ribosylating toxins

(2010) N Lycke et al.   Mucosal Immunology

Mucosal vaccines: novel advances in technology and delivery

(2009) Yoshikazu Yuki et al.   Expert Review of Vaccines

Intranasal Delivery of Cholera Toxin Induces Th17-Dominated T-Cell Response to Bystander Antigens

(2009) Jee-Boong Lee et al.   PLoS One

Cholera toxin structure, gene regulation and pathophysiological and immunological aspects

(2008) J. Sánchez et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Randomized Clinical Trial Assessing the Safety and Immunogenicity of Oral Microencapsulated Enterotoxigenic Escherichia coli Surface Antigen 6 with or without Heat-Labile Enterotoxin with Mutation R192G

(2008) J. A. Lapa et al.   Clinical and Vaccine Immunology